drugset / Trial / NCT07513480
Pretreatment With CPA-EE, Metformin and Myoinositol in PCOS With High AMH
RandomizedParallel-groupOpen-labelTreatment
Summary
Women with PCOS with high AMH randomly allocated into group A \& B.Cyproterone acetate plus ethinyl estradiol,metformin \& myoinositol in group A and Cyproterone acetate plus ethinyl estradiol \& metformin are given in group B.Then letrozole 5 mg day 2 to day 6 is given \& ovarian response is seen in day 12 for 3 subsequent 3 months .
Timeline
- Start
- 2024-08-12
- Primary completion
- 2025-11-12
- Completion
- 2026-02-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Metformin | Small molecule | 500 mg | — |
| Background | cyproterone acetate | Small molecule | 2 mg | — |
| Background | ethinyl estradiol | Small molecule | 35 ug | — |